Life-science briefing: Thursday, April 3, 2008
TODAY’S HEADLINES:
Mirna Thera spins out of Asuragen with $3M (release)
Stroke-therapy startup CoAxia raises $12M (release)
Stealthy device maker Synvascular gets $6.5M (peHUB)
AndroScience seeks $3.5M for anti-testosterone drugs (VentureWire)
Austria’s ProtAffin takes in €1.1M grant (release)
Singapore’s Moleac receives $3.5M for Chinese medicine (release)
Alethia Bio gets C$2.4M for antibody drugs (release)
Alba Thera names Bruce Peacock as CEO (release)
SkinMedica names Mary Fisher as CEO (release)
Mirna Thera spins out of Asuragen with $3M – Mirna Therapeutics, a newly minted Austin, Tex., startup focused… Continue Reading
Impres Medical pulls in $3.2M to stop uterine bleeding
Impres Medical, a Minnetonka, Minn. device maker, has raised $3.2 million of a planned $5 million third round, according to an SEC filing cited by VentureWire (subscription required).
From the VentureWire story:
Investors in the Series C funding included new investors WavePoint Ventures and Johnson and Johnson Development Corp., as well as previous investors Technology Funding and individual investors.
The funding will be used for the development of Impres Medical’s device targeting abnormal uterine bleeding, which works by… Continue Reading